SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity
Abstract
Share and Cite
Tobias, J.; Steinberger, P.; Wilkinson, J.; Klais, G.; Kundi, M.; Wiedermann, U. SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity. Vaccines 2024, 12, 795. https://doi.org/10.3390/vaccines12070795
Tobias J, Steinberger P, Wilkinson J, Klais G, Kundi M, Wiedermann U. SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity. Vaccines. 2024; 12(7):795. https://doi.org/10.3390/vaccines12070795
Chicago/Turabian StyleTobias, Joshua, Peter Steinberger, Joy Wilkinson, Gloria Klais, Michael Kundi, and Ursula Wiedermann. 2024. "SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity" Vaccines 12, no. 7: 795. https://doi.org/10.3390/vaccines12070795
APA StyleTobias, J., Steinberger, P., Wilkinson, J., Klais, G., Kundi, M., & Wiedermann, U. (2024). SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity. Vaccines, 12(7), 795. https://doi.org/10.3390/vaccines12070795